Rollins/$ROL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Rollins

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

Ticker

$ROL

Sector

Business services

Primary listing

NYSE

Employees

20,265

Rollins Metrics

BasicAdvanced
$27B
56.11
$1.01
0.75
$0.65
1.16%

What the Analysts think about Rollins

Analyst ratings (Buy, Hold, Sell) for Rollins stock.

Bulls say / Bears say

Rollins delivered Q2 2025 revenue of $1 billion, up 12.1% year-over-year, with organic revenue growth of 7.3%, driving a 10% increase in adjusted EBITDA to $231 million, underscoring strong demand and pricing power (PRNewswire)
The company’s leverage remained conservative post-acquisition, with net debt to adjusted EBITDAR at just 0.9× as of June 30, 2025, giving Rollins ample capacity for further strategic investments and shareholder returns (PRNewswire)
Rollins completed its $207.1 million acquisition of Saela Holdings in April 2025, expanding its presence in the Pacific Northwest, Mountain West, and Midwest, and the deal is not expected to push pro forma leverage above 1.0×, supporting accretive growth in key U.S. markets (PRNewswire)
Q2 2025 operating margins contracted despite revenue growth, with GAAP operating margin down 60 bps to 19.8% and adjusted operating margin down 30 bps to 20.6%, highlighting pressure from rising employee, insurance, and fleet costs (PRNewswire)
Rollins’ aggressive M&A activity, including $226 million in acquisitions in Q2 and $254 million in the first half of 2025, has led to elevated contingent consideration liabilities (up 91% to $40.2 million) and $132.9 million of goodwill from the Saela deal, increasing the risk of future impairment charges (Panabee)
The EPA’s December 2024 proposal to revoke most food tolerances for chlorpyrifos could constrain Rollins’ chemical toolkit, potentially elevating pesticide costs and compliance burdens across its pest‐control operations (US EPA)
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2025.

Rollins Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Rollins Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ROL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Sept10
Rollins
Dividend·Payment
$0.165Per share
FAQs